JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.
JMP Securities analyst Reni Benjamin maintained a Buy rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of ...
20hon MSN
We recently compiled a list of the 8 AI Stocks on Investors’ Radar. In this article, we are going to take a look at where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback